Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial monoamine oxidases (MAOs) are FAD-dependent oxidative enzymes that catalyze the breakdown of primary and secondary amines and polyamines. While mammalian MAOs are central regulators of neurotransmitters, bacterial homologs (e.g., from *Thermoanaerobacterales* and *Corynebacterium ammoniagenes*) display broad substrate specificity and extreme thermostability, making them attractive tools in synthetic organic chemistry and biosensing[1][2]. The active site features a canonical "aromatic cage", and the high-resolution structures reveal similarities and some differences compared to human MAOs (such as the absence of C-terminal membrane anchoring domains in some bacterial forms)[1][6]. The physiological role of bacterial MAOs is still being investigated; proposed functions include nitrogen scavenging and polyamine degradation[2]. Nitroreductases, while grouped here in the query, comprise a distinct class of FAD-dependent enzymes involved in the reduction of nitro groups; they are functionally unrelated to MAOs and may play roles in antibiotic resistance, drug metabolism, and detoxification, but specific bacterial data is not detailed in the provided sources. *Note:* For future structured work, it is best to handle "Bacterial monoamine oxidase" and "Bacterial nitroreductase" as **separate targets**, as current results do not support conflation without loss of specificity or scientific rigor[1][2][3][6].
Oxidation of monoamines and polyamines to corresponding aldehydes, with reduction of oxygen to hydrogen peroxide via FAD cofactor. Nitroreductase: cytosolic reduction of nitro groups on substrates (not detailed for bacterial forms here).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial monoamine oxidase (MAO).